PortfoliosLab logo
LNTH vs. APLS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LNTH and APLS is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

LNTH vs. APLS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%NovemberDecember2025FebruaryMarchApril
343.44%
24.66%
LNTH
APLS

Key characteristics

Sharpe Ratio

LNTH:

0.92

APLS:

-1.17

Sortino Ratio

LNTH:

1.91

APLS:

-2.00

Omega Ratio

LNTH:

1.26

APLS:

0.76

Calmar Ratio

LNTH:

1.51

APLS:

-0.79

Martin Ratio

LNTH:

3.03

APLS:

-1.72

Ulcer Index

LNTH:

19.17%

APLS:

37.26%

Daily Std Dev

LNTH:

63.11%

APLS:

54.78%

Max Drawdown

LNTH:

-78.62%

APLS:

-81.38%

Current Drawdown

LNTH:

-17.68%

APLS:

-81.26%

Fundamentals

Market Cap

LNTH:

$7.11B

APLS:

$2.20B

EPS

LNTH:

$4.36

APLS:

-$1.60

PS Ratio

LNTH:

4.64

APLS:

2.81

PB Ratio

LNTH:

6.54

APLS:

9.65

Total Revenue (TTM)

LNTH:

$1.16B

APLS:

$609.04M

Gross Profit (TTM)

LNTH:

$746.45M

APLS:

$511.08M

EBITDA (TTM)

LNTH:

$323.70M

APLS:

-$95.68M

Returns By Period

In the year-to-date period, LNTH achieves a 13.76% return, which is significantly higher than APLS's -45.19% return.


LNTH

YTD

13.76%

1M

3.39%

6M

-7.73%

1Y

56.09%

5Y*

49.62%

10Y*

N/A

APLS

YTD

-45.19%

1M

-26.48%

6M

-34.45%

1Y

-63.51%

5Y*

-13.89%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LNTH vs. APLS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LNTH
The Risk-Adjusted Performance Rank of LNTH is 8484
Overall Rank
The Sharpe Ratio Rank of LNTH is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of LNTH is 8585
Sortino Ratio Rank
The Omega Ratio Rank of LNTH is 8585
Omega Ratio Rank
The Calmar Ratio Rank of LNTH is 9090
Calmar Ratio Rank
The Martin Ratio Rank of LNTH is 8080
Martin Ratio Rank

APLS
The Risk-Adjusted Performance Rank of APLS is 33
Overall Rank
The Sharpe Ratio Rank of APLS is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of APLS is 22
Sortino Ratio Rank
The Omega Ratio Rank of APLS is 44
Omega Ratio Rank
The Calmar Ratio Rank of APLS is 66
Calmar Ratio Rank
The Martin Ratio Rank of APLS is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LNTH vs. APLS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for LNTH, currently valued at 0.92, compared to the broader market-2.00-1.000.001.002.003.00
LNTH: 0.92
APLS: -1.17
The chart of Sortino ratio for LNTH, currently valued at 1.91, compared to the broader market-6.00-4.00-2.000.002.004.00
LNTH: 1.91
APLS: -2.00
The chart of Omega ratio for LNTH, currently valued at 1.26, compared to the broader market0.501.001.502.00
LNTH: 1.26
APLS: 0.76
The chart of Calmar ratio for LNTH, currently valued at 1.51, compared to the broader market0.001.002.003.004.005.00
LNTH: 1.51
APLS: -0.79
The chart of Martin ratio for LNTH, currently valued at 3.03, compared to the broader market-5.000.005.0010.0015.0020.00
LNTH: 3.03
APLS: -1.72

The current LNTH Sharpe Ratio is 0.92, which is higher than the APLS Sharpe Ratio of -1.17. The chart below compares the historical Sharpe Ratios of LNTH and APLS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50NovemberDecember2025FebruaryMarchApril
0.92
-1.17
LNTH
APLS

Dividends

LNTH vs. APLS - Dividend Comparison

Neither LNTH nor APLS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LNTH vs. APLS - Drawdown Comparison

The maximum LNTH drawdown since its inception was -78.62%, roughly equal to the maximum APLS drawdown of -81.38%. Use the drawdown chart below to compare losses from any high point for LNTH and APLS. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-17.68%
-81.26%
LNTH
APLS

Volatility

LNTH vs. APLS - Volatility Comparison

The current volatility for Lantheus Holdings, Inc. (LNTH) is 12.99%, while Apellis Pharmaceuticals, Inc. (APLS) has a volatility of 19.30%. This indicates that LNTH experiences smaller price fluctuations and is considered to be less risky than APLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
12.99%
19.30%
LNTH
APLS

Financials

LNTH vs. APLS - Financials Comparison

This section allows you to compare key financial metrics between Lantheus Holdings, Inc. and Apellis Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items